C9H8ClN3O2
225.63 g/mol
Pharmaceutical IntermediateDanger
Carbamic acid, N-(6-chloro-1H-benzimidazol-2-yl)-, methyl ester
CAS20367-38-8
Category
Pharmaceutical Intermediate
Compound Class
Heterocycle
Primary Use
Pharmaceutical Intermediate
This compound is a chemical compound used as a pharmaceutical intermediate. It is primarily employed in the manufacturing process of benzimidazole-class drugs.
Pharmaceutical intermediate for benzimidazole drug production
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Related Compounds
ApplicationSame Use
Methyl [6-(chlorosulfonyl)-1H-benzimidazol-2-yl]carbamate
CAS79213-74-4
pharmaceutical intermediate
ReferenceSame Category
Salcaprozate sodium
CAS203787-91-1
pharmaceutical intermediate
ReferenceSame Category
2-morpholinoethylamine
CAS2038-03-1
pharmaceutical intermediate
ReferenceSame Category
N-BOC-4,4-difluoro-L-proline
CAS203866-15-3
pharmaceutical intermediate
ReferenceSame Category
Tert-Butyl (R)-3-(methylamino)piperidine-1-carboxylate
CAS203941-94-0
pharmaceutical intermediate
Safety Reference
Danger
H340May cause genetic defects
H360May damage fertility or the unborn child
H400Very toxic to aquatic life
H410Very toxic to aquatic life with long lasting effects
Identifiers
IUPAC Name
methyl N-(6-chloro-1H-benzimidazol-2-yl)carbamate
InChIKey
VLEJNRYXCWJNPA-UHFFFAOYSA-N
SMILES
COC(=O)NC1=NC2=C(N1)C=C(C=C2)Cl
Synonyms (19)
- G-981
- ALBENDAZOLE IMPURITY G (EP IMPURITY)
- Albendazole EP Impurity G
- Fenbendazole EP Impurity B
- Albendazole Impurity G
- FENBENDAZOLE IMPURITY B
- Fenbendazole impuity B
- Fenbendazole impurity B CRS
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.